- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/173 - Purine radicals with 2-deoxyribosyl as the saccharide radical
Patent holdings for IPC class C07H 19/173
Total number of patents in this class: 264
10-year publication summary
|
19
|
17
|
11
|
16
|
18
|
14
|
17
|
12
|
14
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2036 |
16 |
| Agilent Technologies, Inc. | 2638 |
10 |
| Nucana plc | 84 |
8 |
| Merck Sharp & Dohme LLC | 3749 |
8 |
| Alnylam Pharmaceuticals, Inc. | 1152 |
7 |
| Illumina Cambridge Limited | 684 |
7 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 288 |
5 |
| Alios BioPharma, Inc. | 66 |
5 |
| ViiV Healthcare Company | 154 |
5 |
| Janssen Biopharma, Inc. | 40 |
5 |
| Ajinomoto Co., Inc. | 2305 |
4 |
| CARIS Science, Inc. | 69 |
4 |
| The Scripps Research Institute | 1348 |
4 |
| Merck Sharp & Dohme Corp. | 2198 |
3 |
| Janssen Pharmaceuticals, Inc. | 433 |
3 |
| Massachusetts Institute of Technology | 10041 |
3 |
| Idenix Pharmaceuticals LLC | 62 |
3 |
| Illumina, Inc. | 3340 |
3 |
| Ionis Pharmaceuticals, Inc. | 868 |
3 |
| Isis Pharmaceuticals, Inc. | 215 |
3 |
| Other owners | 155 |